Country: Malta
Language: English
Source: Medicines Authority
BUDESONIDE
Teva Pharma B.V. (utrecht) Swensweg 5, 2031 GA Haarlem, Netherlands
R03BA02
BUDESONIDE 0.25 mg/ml
NEBULISER SUSPENSION
BUDESONIDE 0.25 mg/ml
POM
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Withdrawn
2011-03-14
_ _ PACKAGE LEAFLET: INFORMATION FOR THE USER BUDESONIDE TEVA 0.5 MG/2 ML NEBULISER SUSPENSION BUDESONIDE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What BUDESONIDE TEVA NEBULISER SUSPENSION is and what it is used for 2. Before you use BUDESONIDE TEVA NEBULISER SUSPENSION 3. How to use BUDESONIDE TEVA NEBULISER SUSPENSION 4. Possible side effects 5. How to store BUDESONIDE TEVA NEBULISER SUSPENSION 6. Further information 1. WHAT BUDESONIDE TEVA NEBULISER SUSPENSION IS AND WHAT IT IS USED FOR Your medicine is called BUDESONIDE TEVA 0.5 mg/2 ml Nebuliser Suspension. Budesonide belongs to a group of medicines called glucocorticosteroids. BUDESONIDE Nebuliser Suspension is used to treat asthma, which makes it difficult for you to breathe. BUDESONIDE NEBULISER SUSPENSION IS NOT SUITABLE FOR THE TREATMENT OF SUDDEN ONSET BREATHING DIFFICULTIES INCLUDING ACUTE ASTHMA ATTACKS. 2. BEFORE YOU USE BUDESONIDE TEVA NEBULISER SUSPENSION DO NOT USE BUDESONIDE TEVA NEBULISER SUSPENSION - if you are allergic (hypersensitive) to budesonide or to any other ingredients of BUDESONIDE NEBULISER SUSPENSION. TAKE SPECIAL CARE WITH BUDESONIDE TEVA NEBULISER SUSPENSION IF: • you have ever had tuberculos Read the complete document
_ _ Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT BUDESONIDE TEVA 0.5 mg / 2 ml Nebuliser Suspension. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 2 ml ampoule contains 0.5 mg budesonide (0.25 mg/ml). For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Nebuliser Suspension. A white to off white suspension. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Budesonide Nebuliser Suspension is indicated in adults, adolescents and in infants and children aged six months to 12 years. BRONCHIAL ASTHMA BUDESONIDE NEBULISER SUSPENSION is indicated for use in bronchial asthma, in patients where use of a pressurised metered dose inhaler or dry powder device is unsatisfactory or inappropriate. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Paediatric population _ The safety and efficacy of Budesonide Nebuliser Suspension in infants aged less than six months has not yet been established. There is no relevant use of Budesonide Nebuliser Suspension in children aged less than six months in the indication. _Method of administration _ For inhalation use only. Precautions to be taken before handling or administrating the medicinal product. BUDESONIDE NEBULISER SUSPENSION IS FOR INHALATION USE. DO NOT USE A PARTIALLY USED, OPENED OR DAMAGED AMPOULE. _ _ Page 2 of 11 BUDESONIDE NEBULISER SUSPENSION should be administered via a suitable nebuliser, which should be designed to provide nebulised particles of an appropriate size to permit passage of droplets into the lungs. Typically these will have a DV(50) < 3µm and Read the complete document